2021 Cross-Border Healthcare Innovation & Partnership Summit
Jan 28, 2021
On Jan 28th, the 2021 Cross-Border Healthcare Innovation & Partnership Summit was successfully held virtually by MSQ Ventures and Bayhelix. This summit consisted of in total 9 company presentations and a panel discussion on "Global Biopharma Collaboration Opportunities and Challenges in 2021". The summit and the panel were well-received and we got highly positive feedback. MSQ Ventures will continue to boost cross-border collaboration and communication in the biopharmaceutical industry.
PANEL DISCUSSION: GLOBAL BIOPHARMA COLLABORATION OPPORTUNITIES AND CHALLENGES IN 2021
2020 has been a challenging year, but fortunately, the biopharma industry is still booming, and the global collaboration in terms of the number of cross-border transactions has reached new highs. We were honored to have Juho Jalkanen, Chief Development Officer at Faron Pharmaceuticals, and Alvin Luk, CEO at Neurophth Therapeutics to join our panel discussion, and discussed how they converted challenges into opportunities in 2020, and their forecasts for the year 2021.